Advertisement
Advertisement

AMRX

AMRX logo

Amneal Pharmaceuticals, Inc. Class A Common Stock

18.14
USD
Sponsored
+0.07
+0.39%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

18.60

+0.46
+2.55%

Amneal Pharmaceuticals, Inc. Class A Common Stock Profile

About

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Info & Links

CEO

Chirag Patel

Headquarters

400 CROSSING BOULEVARD
BRIDGEWATER, NJ 08807, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.amneal.com

Auditor

Ernst & Young LLP

Share holders

159

Employees

8,500

Amneal Pharmaceuticals, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

5.94B

Enterprise Value

8.47B

Enterprise Value/EBITDA(ttm)

12.75

Price to Earnings Ratio(ttm)

21.01

Price to Sales(ttm)

1.85

Price to Book(mrq)

174.56

Price to Cash(ytd)

11.57

Profitability

Gross Margin(ttm)

39.43%

Operating Margin(ttm)

9.10%

Profit Margin(ttm)

5.12%

Return on Equity(ttm)

-584.46%

Return on Invested Capital(ttm)

8.44%

Return on Assets(ttm)

7.78%

Income Statement

Revenue(ttm)

3.12B

Revenue Per Share(ttm)

9.76

Gross Profit(ttm)

1.23B

EBITDA(ttm)3

664.91M

Net Income Available to Common(ttm)

157.36M

Diluted EPS(ttm)

0.49

Share Statistics

Beta (5Y Monthly)

1.27

52-Week Change

120.95%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

319.35M

Dividend Yield

0.00%

Float4

263.83M

% Held by Insiders

17.30%

% Held by Institutions

31.82%

Balance Sheet

Total Cash(mrq)

136.28M

Total Cash Per Share(mrq)

0.43

Total Debt(mrq)

2.67B

Total Debt/Equity(mrq)

8085.93%

Current Ratio(mrq)

2.20%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

0.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.15

Free Cash Flow(ytd)

-107.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement